Learning and advancement

Interventional cadiologist taking notes

Strengthening your care for patients

Industry experts share the latest interventional techniques and provide their advice on how best to adopt them within clinical practice.

About our programs

Edwards Benchmark Program

Our program may support your heart centre in optimising its transcatheter aortic valve implantation (TAVI) care pathway for better patient outcomes.

Learn more

Tips and Techniques

Explore case recordings, expert-delivered educational videos on procedural challenges, tips and techniques, peer interviews and more.

View videos

Learning Portal

Edwards Learning Network, an educational portal for healthcare professionals providing continuous learning and development in structural heart intervention.

Find out more
It began with an idea lightbulb image

Together we sparked a revolution

Hear from key industry physicians about their TAVI experiences.

Learn more

Edwards SAPIEN 3 TAVI

Close up of Edwards SAPIEN 3 Ultra transcatheter heart valve
2018
Edwards SAPIEN 3 Ultra valve

The latest transcathether heart valve in the Edwards portfolio.

Edwards SAPIEN 3 Ultra valve
Close up of Edwards SAPIEN 3 transcatheter heart valve
2014
Edwards SAPIEN 3 valve

The first TAVI valve to receive a CE mark for severe aortic stenosis (sAS) patients at low surgical risk.

Edwards SAPIEN 3 valve
Close up of Edwards SAPIEN XT transcather heart valve
2010
Edwards SAPIEN XT valve

Edwards valve proving non-inferior to surgery on mortality and stroke in the PARTNER IIA Trial.1

Technology and Innovation
Close up of Edwards SAPIEN XT transcather heart valve
2007
Edwards SAPIEN valve

Introduced as a lifesaving treatment option for inoperable and high surgical risk patients.2,3

Explore Edwards Innovation

You refuse to compromise.

We couldn't agree more.

Find out more

Clinical Evidence

Male doctor researching on laptop

PARTNER Trials

Overview of studies conducted with balloon expandable TAVI valves by Edwards Lifesciences.

Read PARTNER data

ESC/EACTS VHD Guidelines

Learn how the Edwards clinical trial programme has shaped the aortic stenosis treatment landscape.

TAVI value and optimisation

Uncover the wide-ranging economic and quality of life benefits possible with the Edwards SAPIEN 3 transcatheter heart valve.4

Speaker speaking at a conference

Events

Visit us at upcoming events

Upcoming events and past event highlights.

Read more
Female interventional cardiologist holding a microphone presenting to a room full of doctors

Resources

Resources for download

Useful for you and your patients, including heart anatomy guide, clinical summary PDFs and more.

Access resources

Stay informed with our newsletter

References:

1. Leon MB, et al. N Engl J Med 2016;374:1609-1620 and supplementary material.
2. Leon MB, Smith CR, Mack M, et al; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607.
3. Smith CR, Leon MB, Mack MJ, et al.; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98.
4. Cohen DJ. Economic Outcomes of TAVR vs SAVR for Low-Risk Patients: Results from PARTNER 3 Trial. Presented at TCT 2021, Orlando Fl. November 5th 2021.

For professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable). Edwards devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.

PP--EU-3351 v1.0